Funded Tech Companies
Mysthera Therapeutics
Wondering who provided funding to Mysthera Therapeutics? Forty51 Ventures joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Mysthera Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
St. Jakobsstrasse 17
Basel, 4052
CH
Basel, 4052
CH
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Mysthera was founded by Forty51 Ventures in Europe's pharma/biotech hub, Basel, in Switzerland in early 2023. The company is a preclinical stage biotech start-up focused on developing first-in-class, oral therapeutics to treat major unmet needs in autoimmune diseases. Our unique approach has potential to transform patient lives in a number of disease settings including glomerulonephritis, rheumatoid arthritis and inflammatory bowel disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/21/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Darren Cunningham
Co-Founder
Stefan Haak
Co-Founder
Marta Marti
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs